COVID-19 and the Nasal Microbiome: Potential Marker of Disease Outcomes and Novel Antivirals

At a Glance

The COVID-19 Response grants awarded by the Faculty Grant support UW–Madison researchers across campus in scientific, medical and public health approaches to lessening the impact of COVID-19 through improved testing, treatments and vaccine development, as well as projects that aim to protect the public and healthcare workforce from the virus.

Project Goals

To study the nasal microbiome to determine potential compositions that are associated with COVID-19 outcomes for predictive biomarkers of disease severity and to discover novel naturally occurring novel antiviral compound